首页> 外国专利> THE USE OF AMIFOSTINE FOR THE PROTECTION AGAINST TUMOR METASTASIS FORMATION

THE USE OF AMIFOSTINE FOR THE PROTECTION AGAINST TUMOR METASTASIS FORMATION

机译:氨磷汀在肿瘤转移形成中的保护作用

摘要

Methods and pharmaceuticals for inhibiting or preventing metastasis formation in animals, including humans, having primary tumors, through the administration of phosphorothioates including their thiol and disulfide metabolites are disclosed. These compounds stimulate angiostatin levels, inhibit matrix metalloproteinases (MMPs), and stimulate manganese superoxidase dismutase (MnSOD). Phosphorothioates, of which amifostine is an example, can be administered as a combination therapy with traditional cancer therapies, including chemotherapy, radiotherapy, surgery, immunotherapy, hormone therapy and gene-therapy. Inhibition or prevention of metastasis by phosphorothioates is independent of tumor type, including adenocarcinomas and sarcomas.
机译:公开了通过给予硫代磷酸酯包括其硫醇和二硫化物代谢物来抑制或预防包括原发性肿瘤的动物(包括人)中转移形成的方法和药物。这些化合物刺激血管生成抑制素水平,抑制基质金属蛋白酶(MMP),并刺激锰超氧化物酶歧化酶(MnSOD)。硫代磷酸酯(例如氨磷汀)可以与传统的癌症疗法(包括化学疗法,放射疗法,手术,免疫疗法,激素疗法和基因疗法)联合治疗。硫代磷酸酯对转移的抑制或预防与肿瘤类型无关,包括腺癌和肉瘤。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号